H J Hoffmann
Overview
Explore the profile of H J Hoffmann including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
62
Citations
1132
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mayorga C, Celik G, Pascal M, Hoffmann H, Eberlein B, Torres M, et al.
Allergy
. 2023 Dec;
79(3):580-600.
PMID: 38084472
Diagnosing immediate drug hypersensitivity reactions (IDHRs) can pose a significant challenge and there is an urgent need for safe and reliable tests. Evidence has emerged that the basophil activation test...
2.
Pascal M, Edelman S, Nopp A, Mobs C, Geilenkeuser W, Knol E, et al.
Allergy
. 2023 Oct;
79(2):290-293.
PMID: 37795777
No abstract available.
3.
Hellings P, Lau S, Scadding G, Bjermer L, Backer V, Chaker A, et al.
Front Allergy
. 2023 Aug;
4:1236977.
PMID: 37577332
In March 2023, the European Forum for Research and Education in Allergy and Airways diseases (EUFOREA) organized its bi-annual Summit in Brussels with expert panel members of EUFOREA, representatives of...
4.
Cardona V, Demoly P, Dreborg S, Kalpaklioglu A, Klimek L, Muraro A, et al.
Allergy
. 2017 Sep;
73(2):323-327.
PMID: 28905404
In the European Union (EU), the regulatory framework regarding diagnostic allergen extracts is currently in the process of being implemented at the national level. Due to these regulations, the initial...
5.
Loft N, Skov L, Iversen L, Gniadecki R, Dam T, Brandslund I, et al.
Pharmacogenomics J
. 2017 Jul;
18(3):494-500.
PMID: 28696418
Biological agents including anti-tumor necrosis factor (anti-TNF; adalimumab, infliximab, etanercept) and anti-interleukin-12/13 (IL12/23; ustekinumab) are essential for treatment of patients with severe psoriasis. However, a significant proportion of the patients...
6.
Bank S, Andersen P, Burisch J, Pedersen N, Roug S, Galsgaard J, et al.
Pharmacogenomics J
. 2017 Feb;
18(1):87-97.
PMID: 28139755
Anti-tumour necrosis factor-α (TNF-α) is used for treatment of severe cases of inflammatory bowel diseases (IBD), including Crohn's disease (CD) and ulcerative colitis (UC). However, one-third of the patients do...
7.
Hoffmann H, Valovirta E, Pfaar O, Moingeon P, Schmid J, Skaarup S, et al.
Allergy
. 2017 Jan;
72(7):1022-1034.
PMID: 28122129
In this review, we report on relevant current topics in allergen immunotherapy (AIT) which were broadly discussed during the first Aarhus Immunotherapy Symposium (Aarhus, Denmark) in December 2015 by leading...
8.
Matricardi P, Kleine-Tebbe J, Hoffmann H, Valenta R, Hilger C, Hofmaier S, et al.
Pediatr Allergy Immunol
. 2016 Jun;
27 Suppl 23:1-250.
PMID: 27288833
The availability of allergen molecules ('components') from several protein families has advanced our understanding of immunoglobulin E (IgE)-mediated responses and enabled 'component-resolved diagnosis' (CRD). The European Academy of Allergy and...
9.
Klimek L, Hammerbacher A, Hellings P, Fokkens W, Hoffmann H, Muraro A, et al.
Rhinology
. 2015 Sep;
53(3):260-9.
PMID: 26363167
In patients with allergic rhinitis (AR), the nasal provocation test (NPT) is the standard procedure to evaluate the clinical response of the nasal mucosa to allergens with a high specificity...
10.
Hansen S, Strom M, Olsen S, Dahl R, Hoffmann H, Granstrom C, et al.
Clin Exp Allergy
. 2015 Sep;
46(2):329-36.
PMID: 26333063
Background: Prenatal exposures to persistent organic pollutants (POPs) have been associated with asthma medication use and self-reported symptoms, but associations with lung function and allergic sensitization have been minimally explored....